PRISCO, DOMENICO
 Distribuzione geografica
Continente #
NA - Nord America 27.732
EU - Europa 17.765
AS - Asia 5.375
SA - Sud America 311
OC - Oceania 263
AF - Africa 134
Continente sconosciuto - Info sul continente non disponibili 8
Totale 51.588
Nazione #
US - Stati Uniti d'America 27.628
RU - Federazione Russa 5.622
PL - Polonia 3.982
HK - Hong Kong 2.029
IE - Irlanda 1.937
IT - Italia 1.758
SG - Singapore 1.725
SE - Svezia 1.586
DE - Germania 762
UA - Ucraina 758
CN - Cina 630
FI - Finlandia 402
IN - India 342
GB - Regno Unito 315
FR - Francia 275
BR - Brasile 273
AU - Australia 257
JO - Giordania 190
TR - Turchia 158
CH - Svizzera 101
VN - Vietnam 100
CA - Canada 92
ID - Indonesia 80
CI - Costa d'Avorio 78
ES - Italia 55
NL - Olanda 47
AT - Austria 38
BE - Belgio 38
SC - Seychelles 32
CZ - Repubblica Ceca 23
KR - Corea 20
IQ - Iraq 12
AR - Argentina 9
SA - Arabia Saudita 9
BD - Bangladesh 8
DK - Danimarca 8
IR - Iran 8
JP - Giappone 8
LT - Lituania 8
EC - Ecuador 7
EU - Europa 7
IL - Israele 7
KG - Kirghizistan 7
LV - Lettonia 7
MX - Messico 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
CO - Colombia 6
GR - Grecia 6
MU - Mauritius 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
CL - Cile 5
MA - Marocco 5
PK - Pakistan 5
RO - Romania 5
ZA - Sudafrica 5
AL - Albania 4
BG - Bulgaria 4
EG - Egitto 4
NO - Norvegia 4
AM - Armenia 3
BO - Bolivia 3
HU - Ungheria 3
NP - Nepal 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
CR - Costa Rica 2
GE - Georgia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
UY - Uruguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
MK - Macedonia 1
MN - Mongolia 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SN - Senegal 1
TH - Thailandia 1
TM - Turkmenistan 1
TN - Tunisia 1
Totale 51.588
Città #
Santa Clara 6.598
Warsaw 3.980
Fairfield 3.249
Dublin 1.920
Chandler 1.797
Hong Kong 1.639
Ashburn 1.545
Woodbridge 1.490
Seattle 1.296
Cambridge 1.220
Jacksonville 1.220
Houston 1.169
Wilmington 1.052
Singapore 962
Ann Arbor 520
Lawrence 506
Princeton 501
Altamura 472
Florence 339
Boston 313
Mumbai 302
Boardman 277
Melbourne 253
Medford 241
Beijing 222
Buffalo 214
Moscow 210
San Diego 191
Paris 178
New York 137
Shanghai 135
Los Angeles 120
Bern 94
Norwalk 86
Jakarta 79
Abidjan 78
Izmir 78
Dong Ket 76
Falls Church 73
Milan 69
Kent 65
Helsinki 63
Toronto 63
Hillsboro 56
London 47
Andover 43
Auburn Hills 43
Barcelona 41
Yubileyny 39
Brussels 38
Munich 38
Vienna 37
Rome 36
Frankfurt Am Main 31
Redwood City 28
West Jordan 28
Phoenix 27
Dearborn 26
Latina 26
Verona 26
São Paulo 24
Guangzhou 22
Salerno 22
The Dalles 19
Brno 17
Washington 17
Seoul 16
Bologna 15
Redmond 13
Bari 12
Fuzhou 12
Prato 12
Arezzo 11
Castelliri 11
Falkenstein 11
Kilburn 11
Palermo 11
Pune 11
Belo Horizonte 10
Frankfurt am Main 10
Laurel 10
Siena 10
Naples 9
Romola 9
North Bergen 8
Ottawa 8
Turin 8
Wuhan 8
Amman 7
Bishkek 7
Copenhagen 7
Genoa 7
Istanbul 7
Newark 7
Old Bridge 7
Riga 7
Baghdad 6
Baku 6
Chicago 6
Curitiba 6
Totale 36.139
Nome #
Behçet's syndrome patients exhibit specific microbiome signature. 303
Erythrocyte oxidative stress is associated with cell deformability in patients with retinal vein occlusion 289
Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection 288
An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions. 282
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 266
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. 263
A severe case of warfarin-canrenoate interaction: a role for genetic predisposition? 258
High lipoprotein (a) levels are associated with an increased risk of retinal vein occlusion 249
Effect of low-dose heparin treatment on fibrinolysis in patients with previous myocardial infarction 247
Central vein sign differentiates MS from CNS inflammatory vasculopathies. 246
Risk of bleeding in very old atrial fibrillation patients on warfarin: Relationship with ageing and CHADS(2) score 244
Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis 243
Vascular and connective tissue features in 5 italian patients with homocystinuria 243
Intra-tumoral IFN-gamma-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer 237
Repeated low-dose courses of rituximab in SLE-associated antiphospholipid syndrome: Data from a tertiary dedicated centre 237
Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events. 236
Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment 235
Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome. 235
Angiotensi-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinmeia increase first-trimester fetal-loss susceptibility 233
Role of glycoprotein Ia gene polymorphisms in determinino platelet function in myocardial infarction patients undergoing percutaneous coronary intervention of dual antiplatelet treatment 231
Diagnosis and treatment of pulmonary embolism: a multidisciplinary approach. 230
Evaluation of traditional and emerging cardiovascular risk factors in patients with non-arteritic anterior ischemic optic neuroparty: a case-control study 224
Sirt1 Protects against Oxidative Stress-Induced Apoptosis in Fibroblasts from Psoriatic Patients: A New Insight into the Pathogenetic Mechanisms of Psoriasis 219
Apolipoprotein(a) kringle-IV type 2 copy number variation is associated with venous thromboembolism 215
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 209
Perioperative assessment of platelet function by Thromboelastograph Platelet MappingTM in cardiovascular patients undergoing non-cardiac surgery 209
Perioperative myocardial infarction in elderly patients with hip fracture. Is there a role for early coronary angiography? 203
Point-of-care testing of hemostasis in cardiac surgery 201
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 201
Aumentata produzione di trombossano A2 e di PGE2 con normale conversione di 1-14 C acido arachidonico da parte delle piastrine nei soggetti diabetici. 189
T cells in gastric cancer: friends or foes. 184
First report of FIP1L1-PDGFR alpha-positive eosinophilic granulomatosis with polyangiitis 183
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 183
D-dimer concentrations during normal pregnancy, as measured by ELISA 173
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 173
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper. 169
Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism 168
Altered intraplatelet arachidonic acid metabolism during the acute state of unstable angina 168
D-Dimer in intra-uterine growth retardation and gestational hypertension 168
Thrombosis in vasculitis: from pathogenesis to treatment 167
Hip fracture unit: beyond orthogeriatrics 166
Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients 161
Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment 160
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 158
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 158
Behcet's Syndrome as a Model of Thrombo-Inflammation: The Role of Neutrophils 157
Platelet synthesis of cyclooxygenase and lipoxygenase products in type I and type II diabetes 155
Gastric cancer and the epoch of immunotherapy approaches 152
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 151
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 150
Prostaglandins in squamous cell carcinoma of the larynx: tumor and peritumor synthesis 149
Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy 149
Intravenous immunoglobulin for the secondary prevention of stillbirth in obstetric antiphospholipid syndrome: A case series and systematic review of literature 149
Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the prolong study 148
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies 147
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 147
The high prevalence of thermolabile 5,10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD) 146
Role of haemorheological factors in patients with retinal vein occlusion. 146
ACE DD genotype: an independent predisposition factor to venous thromboembolism. 145
Stem-Cell-Derived Circulating Progenitors Dysfunction in Behçet's Syndrome Patients Correlates With Oxidative Stress 145
Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina 143
D-dimer plasma levels during normal pregnancy measured by specific ELISA 142
Hyperhomocysteinemia in renal transplant patients as independent cause of endothelial damage and cardiovascular disease. 141
Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer 140
D-dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction? A pilot study 140
Fibrinolytic inhibitors and fibrin characteristics determine a hypofibrinolytic state in patients with pulmonary embolism. 140
Relationship between classical FDP test and D-dimer assayed both by latex agglutination and ELISA 139
D-dimer and fibrinolytic activity in patients with liver cirrhosis and ascites. Preliminary results. 139
Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments? 139
Age related changes in platelet lipid composition 139
Effect of low-dose heparin on fibrinogen levels in patients with chronic ischemic heart disease. 138
RISK FACTORS FOR CARDIOVASCULAR DISEASE IN RENAL TRANSPLANT RECIPIENTS: NEW INSIGHTS 137
Altered membrane fatty acid composition and increased thromboxane A2 generation in platelets from patients with diabetes 137
Blood clotting activation during normal pregnancy 137
Association between time of increased fibrinopeptide A levels in plasma and episodes of spontaneous angina: a controlled prospective study 136
Different models for oral anticoagulation management may be applied provided that minimal assistance criteria are fulfilled: An italian experience 136
Spontaneous and cold pressor test-induced prostaglandin biosynthesis by human heart 136
Factors influencing platelet aggregation in whole blood 136
The pre-procedural platelet state predicts clinical recurrence after coronary angioplasty 135
Ability of whole blood aggregometer to detect platelet hyperaggregability 135
Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic. 135
No signs of increased thrombin generation in menopause 135
Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies. 135
Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the Prolong II prospective study 135
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome 135
Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients. 134
Fibrinolysis alterations in infertile women during controlled ovarian stimulation: Influence of BMI and genetic components. 134
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 134
Predictive value for thrombotic disease of plasminogen activator inhibitor-1 plasma levels 134
Blood velocity in the coronary artery circulation: relation to thromboxane A2 levels in coronary sinus in patients with angiographically normal coronary arteries 134
Interleukin-17/Interleukin-21 and Interferon-g producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome 134
Acute T-cell activation is detectable in unstable angina 133
Impaired cardiac PGI2 and PGE2 biosynthesis in patients with angina pectoris 133
Fibrin generation and digestion in patients with angina pectoris 133
Erythrocyte membrane fluidity alterations in sudden sensorineural hearing loss patients: The role of oxidative stress 133
Evaluation of clotting and fibrinolytic activation after protracted physical exercise 132
Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus 132
Fast curing of restorative materials through the soft light energy release 132
Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels. 132
Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet’s Disease 132
Totale 17.376
Categoria #
all - tutte 152.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.746


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.251 0 0 0 0 0 0 0 0 0 450 594 207
2020/20215.330 424 406 398 788 289 541 228 426 473 663 288 406
2021/20223.303 88 201 321 155 139 177 100 250 191 126 619 936
2022/20237.923 824 1.491 353 488 605 1.456 1.053 412 773 63 234 171
2023/20243.077 115 329 572 175 199 466 103 585 46 163 156 168
2024/202518.370 677 2.166 1.290 3.134 5.685 2.537 333 1.134 1.076 338 0 0
Totale 52.074